RINAT NEUROSCIENCE CORP.
52Patents
48Active
52Granted
50Portfolio score
Filing activity: Oct 8, 2003 → Apr 13, 2020 · 13 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8080243B2 | Isolated antibody which specifically binds to PCSK9 | Chemistry; Metallurgy | 98 | Active |
| US8871908B2 | Antibodies specific for Trop-2 and their uses | Chemistry; Metallurgy | 70 | Active |
| US7252822B2 | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist | Chemistry; Metallurgy | 61 | Expired |
| US8426363B2 | Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9 | Chemistry; Metallurgy | 53 | Active |
| US8399646B2 | Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibody | Chemistry; Metallurgy | 53 | Active |
| US7425329B2 | Methods for treating bone cancer pain by administering a nerve growth factor antagonist | Chemistry; Metallurgy | 51 | Expired |
| US7255860B2 | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody | Chemistry; Metallurgy | 50 | Expired |
| US8007794B2 | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same | Chemistry; Metallurgy | 50 | Active |
| US9029515B2 | Anti-PCSK9 antibodies with pH dependent antigen binding | Chemistry; Metallurgy | 35 | Active |
| US9527926B2 | Heterodimeric proteins and methods for producing and purifying them | Chemistry; Metallurgy | 34 | Active |
| US9676871B2 | Engineered polypeptide conjugates and methods for making thereof using transglutaminase | Chemistry; Metallurgy | 27 | Active |
| US8088384B2 | Anti-NGF antibodies and methods using same | Chemistry; Metallurgy | 19 | Active |
| US9399074B2 | Antibodies specific for trop-2 and their uses | Chemistry; Metallurgy | 19 | Active |
| US8540990B2 | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same | Chemistry; Metallurgy | 18 | Active |
| US7763250B2 | Antibodies directed against amyloid-beta peptide and nucleic acids encoding same | Chemistry; Metallurgy | 18 | Active |
| US8034346B2 | Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same | Chemistry; Metallurgy | 18 | Active |
| US7927594B2 | Antibodies directed against amyloid-beta peptide | Chemistry; Metallurgy | 16 | Expired |
| US8557245B2 | Methods for treating bone cancer by administering a nerve growth factor antagonist antibody | Chemistry; Metallurgy | 15 | Active |
| US8338576B2 | Antibodies specific for DKK-1 and their uses | Chemistry; Metallurgy | 10 | Active |
| US10138303B2 | Heterodimeric proteins and methods for producing and purifying them | Chemistry; Metallurgy | 10 | Active |
| US10155037B2 | Anti-PD-1 antibodies and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US8715673B2 | Staphylococcus aureus specific antibodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9212222B2 | Anti-NGF antibodies and methods using same | Chemistry; Metallurgy | 2 | Active |
| US9175093B2 | PCSK9 antagonists | Chemistry; Metallurgy | 2 | Active |
| US7935342B2 | Methods for treating obesity by administering a trkB antagonist | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.